14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $3.20 $4.97 Thursday, 2nd May 2024 ALDX stock ended at $4.21. This is 0.238% more than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 3.57% from a day low at $4.09 to a day high of $4.24.
90 days $2.71 $4.97
52 weeks $1.42 $11.97

Historical Aldeyra Therapeutics prices

Date Open High Low Close Volume
Feb 22, 2023 $6.99 $7.09 $6.88 $6.94 282 637
Feb 21, 2023 $7.05 $7.25 $6.86 $7.03 635 522
Feb 17, 2023 $6.77 $7.12 $6.61 $7.11 437 649
Feb 16, 2023 $6.34 $6.89 $6.34 $6.76 446 353
Feb 15, 2023 $6.24 $6.43 $6.19 $6.41 244 581
Feb 14, 2023 $6.23 $6.37 $6.20 $6.28 279 919
Feb 13, 2023 $6.33 $6.37 $6.15 $6.25 243 442
Feb 10, 2023 $6.40 $6.40 $6.21 $6.32 338 711
Feb 09, 2023 $6.56 $6.58 $6.30 $6.43 314 458
Feb 08, 2023 $6.70 $6.92 $6.52 $6.52 525 487
Feb 07, 2023 $6.64 $6.91 $6.42 $6.77 1 034 651
Feb 06, 2023 $6.15 $6.29 $6.12 $6.19 214 151
Feb 03, 2023 $6.12 $6.24 $6.09 $6.18 265 867
Feb 02, 2023 $6.10 $6.21 $6.05 $6.20 276 965
Feb 01, 2023 $5.97 $6.14 $5.88 $6.07 260 954
Jan 31, 2023 $5.86 $6.03 $5.84 $5.90 273 251
Jan 30, 2023 $6.04 $6.09 $5.75 $5.77 347 107
Jan 27, 2023 $5.93 $6.26 $5.93 $6.09 363 551
Jan 26, 2023 $6.08 $6.17 $6.01 $6.08 260 959
Jan 25, 2023 $6.01 $6.14 $5.90 $6.08 281 514
Jan 24, 2023 $6.07 $6.18 $5.94 $6.06 285 779
Jan 23, 2023 $6.28 $6.32 $6.07 $6.11 257 525
Jan 20, 2023 $6.19 $6.36 $6.08 $6.32 254 200
Jan 19, 2023 $6.03 $6.16 $5.97 $6.10 315 525
Jan 18, 2023 $6.25 $6.37 $6.05 $6.07 380 500
Click to get the best stock tips daily for free!

About Aldeyra Therapeutics

Aldeyra Therapeutics Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-629, a first-in-class orally administered RASP modulator that is Phase II clinical tria... ALDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT